Gait Disorders, Neurologic Clinical Trial
Official title:
Effects of Vestibular Rehabilitation in Patients With Severe Traumatic Brain Injury: a Randomized Controlled Trial
Verified date | June 2021 |
Source | I.R.C.C.S. Fondazione Santa Lucia |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Severe brain injury (sTBI) is one of the most common causes of long-term disability and is considered the most frequent cause of mortality and serious disability in young adults in industrialized countries. It is defined as an alteration of brain function with loss of consciousness in the acute phase for at least 24 hours (Glasgow Coma Scale (GCS) <8) and it can induce a wide range of deficit, including cognitive-behavioural, motors, psychics, language, vision, coordination and balance impairments. Chronic vestibular symptoms such as dizziness and balance deficits (both static and dynamic postural instability) are present in patients with brain injury. These aspects can cause functions limitation and psychological distress, negatively impacting negatively on subjects' quality of life and social reintegration and are considered unfavourable prognostic factors of the recovery process. The literature supports the use of vestibular rehabilitation techniques in patients with mild and moderate brain injury, however, to date, no studies investigated the effect of vestibular rehabilitation in sTBI patients. The main aim of this randomized controlled trail is to verify the effect of a personalized vestibular training on balance and gait disorders in sTBI patients.
Status | Completed |
Enrollment | 30 |
Est. completion date | June 21, 2021 |
Est. primary completion date | February 26, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 15 Years to 65 Years |
Eligibility | Inclusion Criteria: - Age between 15 and 65 years; - Glasgow coma scale (GCS) score = 8 (used to objectively describe the severity of impaired consciousness at the time of injury) - Level of cognitive functioning (LCF) =7; - Ability to understand verbal commands and the informed consent. - Presence of static and dynamic balance impairments. - Functional Ambulation Classification (FAC) = 3 Exclusion Criteria: - Glasgow coma scale (GCS) score >8 - Level of cognitive functioning (LCF) <7 - Inability to understand verbal commands - Absence of static and dynamic balance impairments. - Functional Ambulation Classification (FAC) < 3 |
Country | Name | City | State |
---|---|---|---|
Italy | Marco Tramontano | Roma | Rm |
Italy | Santa Lucia Foundation I.R.C.C.S. | Roma | Rm |
Lead Sponsor | Collaborator |
---|---|
I.R.C.C.S. Fondazione Santa Lucia |
Italy,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Dynamic Gait Index Scoring Form (DGI) | Change of Dynamic Gait Index Scoring Form (DGI) from baseline at 4 weeks of training, at 4 weeks after the end of the training and after 8 weeks after the end of the training. DGI values ranging from 0 to 24, where 0 means the worse outcome and 24 the best one. | Baseline to 8 weeks after the end training | |
Secondary | Berg Balance Scale (BBS) | Change of Berg Balance Scale (BBS) from baseline at 4 weeks of training, at 4 weeks after the end of the training and after 8 weeks after the end of the training. BBS values ranging from 0 to 56, where 0 means the worse outcome and 56 the best one | Baseline to 8 weeks after the end training | |
Secondary | Community Balance & Mobility Scale (CB&M) | Change of Community Balance and Mobility Scale (CB&M) from baseline at 4 weeks of training, at 4 weeks after the end of the training and after 8 weeks after the end of the training. CB&M values ranging from 0 to 96, where 0 means the worse outcome and 96 the best one. | Baseline to 8 weeks after the end training | |
Secondary | Activities-specific Balance Confidence scale (ABC) | Change of Activities-specific Balance Confidence scale (ABC) from baseline at 4 weeks of training, at 4 weeks after the end of the training and after 8 weeks after the end of the training. ABC values ranging from 0% to 100%, where 0% means the worse outcome and 100% the best one. | Baseline to 8 weeks after the end training | |
Secondary | Community Integration Questionnaire (CIQ) | Change of Community Integration Questionnaire (CIQ) from baseline at 4 weeks of training, at 4 weeks after the end of the training and after 8 weeks after the end of the training. CIQ values ranging from 0 to 29, where 0means the worse outcome and 29 the best one. | Baseline to 8 weeks after the end training | |
Secondary | Dizziness Handicap Inventory (DHI) | Dizziness Handicap Inventory (DHI) from baseline at 4 weeks of training, at 4 weeks after the end of the training and after 8 weeks after the end of the training. DHI values ranging from 0 to 100, where 100 means the worse outcome and 0 the best one. | Baseline to 8 weeks after the end training | |
Secondary | Instrumental Assessment | Postural and gait functional assessment performed using inertial motion capture systems (Opal, APDM Inc., Portland, Oregon, USA, portable devices controlling 6 inertial/magnetic measurement units providing 3D orientation and kinematic). The assessments were performed at the baseline, 4 weeks of training, at 4 weeks after the end of the training and after 8 weeks after the end of the training | Baseline to 8 weeks after the end training |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03593512 -
Deep Brain Stimulation for Autonomic and Gait Symptoms in Multiple System Atrophy
|
N/A | |
Completed |
NCT04117737 -
A Pilot Study of Virtual Reality and Antigravity Treadmill for Gait Improvement in Parkinson
|
N/A | |
Recruiting |
NCT04265482 -
Community-based Cohort of Functional Decline in Subjective Cognitive Complaint Elderly
|
||
Completed |
NCT03192046 -
Bracing for Walking in Parkinson's Disease
|
N/A | |
Terminated |
NCT01678547 -
Robot Walking Rehabilitation in Stroke Patients
|
N/A | |
Recruiting |
NCT05510739 -
Support for Physical Activity in Everyday Life With Parkinson's Disease
|
N/A | |
Recruiting |
NCT05417399 -
Influence of Hawthorne Effect and Dual-tasks on Gait in CP
|
||
Completed |
NCT05683925 -
Effect of Transcutaneous Auricular Vagus Nerve Stimulation on Gait Characteristics in Parkinson's Disease
|
N/A | |
Recruiting |
NCT05110053 -
Spinal Cord sTimulation thEraPy for Parkinson's Disease Patients With Gait Problems
|
Phase 1 | |
Recruiting |
NCT05801874 -
Gait and Posture Analysis in Hemiparetic Patients Through Optoelectronic Systems, "Smart" Tools and Clinical Evaluation
|
||
Recruiting |
NCT04137146 -
SNS for Treatment of PD Gait Disorder
|
N/A | |
Terminated |
NCT05622786 -
Effect of High-Intensity Gait Training Using a Treadmill on Locomotion Recovery in Traumatic Brain Injury Patients
|
N/A | |
Recruiting |
NCT04855825 -
Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS
|
N/A | |
Recruiting |
NCT05022147 -
Enhancing Gait Using Alternating-Frequency DBS in Parkinson Disease
|
Phase 1 | |
Completed |
NCT04266743 -
FeetMe® Monitor: Alternative for the Evaluation of Gait Speed After Stroke
|
N/A | |
Completed |
NCT04622657 -
Validity Reliability of The Dubousset Functional Test in Parkinson Disease
|
N/A | |
Completed |
NCT02356536 -
The Effect of a Wearable Cueing Device on Freezing of Gait in Parkinson's Disease
|
Phase 1 | |
Completed |
NCT00914095 -
Study of Methylphenidate to Treat Gait Disorders And Attention Deficit In Parkinson's Disease (PARKGAIT-II)
|
Phase 4 | |
Completed |
NCT01108029 -
Study of Memantine for Gait Disorders And Attention Deficit In Parkinson's Disease
|
Phase 4 | |
Completed |
NCT03314610 -
Effect of Need to Void on Parkinsonian Gait
|